The British Joint Committee on Vaccination and Immunisation recommended that a meningitis B jab be added to the routine childhood vaccination schedule. But thanks to pricing negotiations, the administration of GlaxoSmithKline's ($GSK)--formerly Novartis' ($NVS)--Bexsero to babies aged two months, four months and 12-13 months began just this week. More